171 related articles for article (PubMed ID: 10832225)
21. Treatment costs and quality of life with granulocyte-macrophage colony-stimulating factor in patients with antineoplastic therapy-related febrile neutropenia. Results of a randomised placebo-controlled trial.
Uyl-de Groot CA; Vellenga E; de Vries EG; Löwenberg B; Stoter GJ; Rutten FF
Pharmacoeconomics; 1997 Sep; 12(3):351-60. PubMed ID: 10170460
[TBL] [Abstract][Full Text] [Related]
22. Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: a systematic review.
Bohlius J; Reiser M; Schwarzer G; Engert A
Br J Haematol; 2003 Aug; 122(3):413-23. PubMed ID: 12877668
[TBL] [Abstract][Full Text] [Related]
23. Clinical use of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in neutropenia associated with malignancy.
Lifton R; Bennett JM
Hematol Oncol Clin North Am; 1996 Aug; 10(4):825-39. PubMed ID: 8811304
[TBL] [Abstract][Full Text] [Related]
24. [G-CSF versus GM-CSF in the treatment of neutropenia in a patient with Felty's syndrome on hemodialysis].
del Pozo C; Ortiz de Salazar MI; Torregrosa I; Sánchez L; Albero MD; Bauza J
Nefrologia; 2000; 20(5):455-8. PubMed ID: 11100668
[TBL] [Abstract][Full Text] [Related]
25. Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial.
Ravaud A; Chevreau C; Cany L; Houyau P; Dohollou N; Roché H; Soubeyran P; Bonichon F; Mihura J; Eghbali H; Tabah I; Bui BN
J Clin Oncol; 1998 Sep; 16(9):2930-6. PubMed ID: 9738560
[TBL] [Abstract][Full Text] [Related]
26. Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib.
Schroten H; Roesler J; Breidenbach T; Wendel U; Elsner J; Schweitzer S; Zeidler C; Burdach S; Lohmann-Matthes ML; Wahn V
J Pediatr; 1991 Nov; 119(5):748-54. PubMed ID: 1719175
[TBL] [Abstract][Full Text] [Related]
27. Recombinant human granulocyte colony-stimulating factor in preterm neonates with sepsis and relative neutropenia: a randomized, single-blind, non-placebo-controlled trial.
Gathwala G; Walia M; Bala H; Singh S
J Trop Pediatr; 2012 Feb; 58(1):12-8. PubMed ID: 21296862
[TBL] [Abstract][Full Text] [Related]
28. Use of myeloid colony-stimulating factors in neonates with septicemia.
Bernstein HM; Calhoun DA; Christensen RD
Curr Opin Pediatr; 2002 Feb; 14(1):91-4. PubMed ID: 11880741
[TBL] [Abstract][Full Text] [Related]
29. Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF): an appraisal of its pharmacoeconomic status in neutropenia associated with chemotherapy and autologous bone marrow transplant.
Goa KL; Bryson HM
Pharmacoeconomics; 1994 Jan; 5(1):56-77. PubMed ID: 10146867
[TBL] [Abstract][Full Text] [Related]
30. Granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor and neutrophils in the bronchoalveolar lavage fluid of premature infants with respiratory distress syndrome.
Papoff P; Christensen RD; Calhoun DA; Juul SE
Biol Neonate; 2001 Aug; 80(2):133-41. PubMed ID: 11509813
[TBL] [Abstract][Full Text] [Related]
31. A randomized case-controlled study of recombinant human granulocyte colony stimulating factor for the treatment of sepsis in preterm neutropenic infants.
Aktaş D; Demirel B; Gürsoy T; Ovalı F
Pediatr Neonatol; 2015 Jun; 56(3):171-5. PubMed ID: 25458637
[TBL] [Abstract][Full Text] [Related]
32. Plasma concentrations of granulocyte-macrophage colony-stimulating factor and interleukin-6 in septic and healthy preterms.
Kantar M; Kültürsay N; Kütükçüler N; Akisü M; Cetingül N; Caglayan S
Eur J Pediatr; 2000 Mar; 159(3):156-7. PubMed ID: 10664226
[TBL] [Abstract][Full Text] [Related]
33. Correction of neutropenia associated with chronic lymphocytic leukaemia following treatment with granulocyte-macrophage colony-stimulating factor.
Hollander AA; Kluin-Nelemans HC; Haak HR; Stern AC; Willemze R; Fibbe WE
Ann Hematol; 1991 Feb; 62(1):32-4. PubMed ID: 2031965
[TBL] [Abstract][Full Text] [Related]
34. The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.
Liang DC
Paediatr Drugs; 2003; 5(10):673-84. PubMed ID: 14510625
[TBL] [Abstract][Full Text] [Related]
35. Granulocyte and granulocyte macrophage colony-stimulating factors as therapy in human and veterinary medicine.
Fernández-Varón E; Villamayor L
Vet J; 2007 Jul; 174(1):33-41. PubMed ID: 17029990
[TBL] [Abstract][Full Text] [Related]
36. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
Kocherlakota P; La Gamma EF
Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
[TBL] [Abstract][Full Text] [Related]
37. Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.
Bregni M; Siena S; Di Nicola M; Dodero A; Peccatori F; Ravagnani F; Danesini G; Laffranchi A; Bonadonna G; Gianni AM
J Clin Oncol; 1996 Feb; 14(2):628-35. PubMed ID: 8636780
[TBL] [Abstract][Full Text] [Related]
38. Southwestern Internal Medicine Conference: clinical use of hematopoietic growth factors.
Fleischman RA
Am J Med Sci; 1993 Apr; 305(4):248-73. PubMed ID: 7682752
[TBL] [Abstract][Full Text] [Related]
39. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and rhG-CSF in the treatment of a child with severe chronic neutropenia.
Mori PG; Pasino M; Dufour C; Boeri E; Molinari AC
Blood; 1994 Nov; 84(9):3244-5. PubMed ID: 7524771
[No Abstract] [Full Text] [Related]
40. [Prevention and treatment of febrile neutropenia].
Montemurro F; Gallicchio M; Aglietta M
Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
